Ashraf A. Tabll

1.4k total citations
81 papers, 1.1k citations indexed

About

Ashraf A. Tabll is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ashraf A. Tabll has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 44 papers in Hepatology and 16 papers in Molecular Biology. Recurrent topics in Ashraf A. Tabll's work include Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (27 papers) and Liver Disease Diagnosis and Treatment (25 papers). Ashraf A. Tabll is often cited by papers focused on Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (27 papers) and Liver Disease Diagnosis and Treatment (25 papers). Ashraf A. Tabll collaborates with scholars based in Egypt, Croatia and United States. Ashraf A. Tabll's co-authors include Elrashdy M. Redwan, Mostafa K. El Awady, Abdelfattah M. Attallah, Yasmine S. El, Noha G. Bader El Din, Reem El‐Shenawy, Martina Smolić, Robert Smolić, Mohamed M. Omran and Samar Samir Youssef and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Virology.

In The Last Decade

Ashraf A. Tabll

79 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf A. Tabll Egypt 19 426 397 255 115 114 81 1.1k
Guiqiang Wang China 22 613 1.4× 511 1.3× 260 1.0× 197 1.7× 115 1.0× 100 1.6k
Martina Friesland Germany 20 657 1.5× 844 2.1× 173 0.7× 76 0.7× 26 0.2× 31 1.5k
Torahiko Tanaka Japan 16 608 1.4× 751 1.9× 279 1.1× 161 1.4× 22 0.2× 28 1.3k
M. Azim Ansari United Kingdom 21 509 1.2× 360 0.9× 447 1.8× 74 0.6× 51 0.4× 61 1.4k
Prasoon Chaturvedi United States 20 657 1.5× 50 0.1× 679 2.7× 208 1.8× 173 1.5× 48 2.2k
Peng Xiao United States 20 307 0.7× 106 0.3× 275 1.1× 621 5.4× 36 0.3× 70 1.4k
Ryoichi Okamoto Japan 23 574 1.3× 426 1.1× 381 1.5× 65 0.6× 44 0.4× 72 1.6k
Marc P. Windisch South Korea 21 574 1.3× 565 1.4× 502 2.0× 226 2.0× 25 0.2× 57 1.6k
Rong Yang China 20 671 1.6× 441 1.1× 213 0.8× 76 0.7× 19 0.2× 70 2.0k
Richard A. Urbanowicz United Kingdom 24 432 1.0× 484 1.2× 281 1.1× 246 2.1× 6 0.1× 50 1.5k

Countries citing papers authored by Ashraf A. Tabll

Since Specialization
Citations

This map shows the geographic impact of Ashraf A. Tabll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf A. Tabll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf A. Tabll more than expected).

Fields of papers citing papers by Ashraf A. Tabll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf A. Tabll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf A. Tabll. The network helps show where Ashraf A. Tabll may publish in the future.

Co-authorship network of co-authors of Ashraf A. Tabll

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf A. Tabll. A scholar is included among the top collaborators of Ashraf A. Tabll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf A. Tabll. Ashraf A. Tabll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tabll, Ashraf A., et al.. (2024). Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology. 602. 110307–110307. 1 indexed citations
3.
4.
Petrovic, Ana G., Lucija Kuna, Tomislav Kizivat, et al.. (2024). Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model. Current Issues in Molecular Biology. 46(8). 8981–8994. 6 indexed citations
5.
6.
Bojanić, Kristina, Gordana Ivanac, Martina Smolić, et al.. (2023). Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
7.
Tabll, Ashraf A., Sayed Sartaj Sohrab, Ahmed Ali, et al.. (2023). Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens. 13(1). 38–38. 4 indexed citations
8.
Petrovic, Ana G., et al.. (2023). Antimicrobial Resistance and Antimicrobial Stewardship: Before, during and after the COVID-19 Pandemic. SHILAP Revista de lepidopterología. 14(2). 727–740. 10 indexed citations
9.
Hessien, Mohamed, Thoria Donia, Ashraf A. Tabll, et al.. (2023). Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?. Viruses. 15(5). 1040–1040. 7 indexed citations
10.
11.
Omran, Mohamed M., Khaled Farid, Ashraf A. Tabll, et al.. (2023). Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines. 11(7). 1852–1852. 25 indexed citations
12.
Tabll, Ashraf A., et al.. (2023). MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection. Medicina. 59(1). 173–173. 3 indexed citations
13.
Elbahrawy, Ashraf, et al.. (2023). Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses. 15(1). 214–214. 25 indexed citations
14.
Bilić-Ćurčić, Ines, Tomislav Kizivat, Ana G. Petrovic, et al.. (2022). Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 7 indexed citations
15.
El‐Kafrawy, Sherif A., Aymn T. Abbas, Sayed Sartaj Sohrab, et al.. (2021). Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection. Pharmaceuticals. 14(6). 511–511. 13 indexed citations
16.
Abbas, Aymn T., Sherif A. El‐Kafrawy, Sayed Sartaj Sohrab, et al.. (2020). Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model. Vaccines. 8(4). 634–634. 16 indexed citations
17.
Din, Noha G. Bader El, Ashraf A. Tabll, M. M. Mashaly, et al.. (2017). Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus. Viral Immunology. 30(5). 359–365. 8 indexed citations
18.
Tabll, Ashraf A., Yasmine S. El, Noha G. Bader El Din, et al.. (2013). MOUSE MONOCLONAL ANTIBODY TOWARDS E1 SPECIFIC EPITOPE BLOCKS VIRAL ENTRY AND INTRACELLULAR VIRAL REPLICATIONIN VITRO. Journal of Immunoassay and Immunochemistry. 35(1). 60–73. 6 indexed citations
19.
Redwan, Elrashdy M. & Ashraf A. Tabll. (2007). Camel Lactoferrin Markedly Inhibits Hepatitis C Virus Genotype 4 Infection of Human Peripheral Blood Leukocytes. Journal of Immunoassay and Immunochemistry. 28(3). 267–277. 105 indexed citations
20.
Tabll, Ashraf A., et al.. (2007). Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C Virus. Journal of Immunoassay and Immunochemistry. 29(1). 91–104. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guiqiang Wang Breakdown of academic impact, for papers by Martina Friesland Breakdown of academic impact, for papers by Torahiko Tanaka Breakdown of academic impact, for papers by M. Azim Ansari Breakdown of academic impact, for papers by Prasoon Chaturvedi Breakdown of academic impact, for papers by Peng Xiao Breakdown of academic impact, for papers by Ryoichi Okamoto Breakdown of academic impact, for papers by Marc P. Windisch Breakdown of academic impact, for papers by Rong Yang Breakdown of academic impact, for papers by Richard A. Urbanowicz
Rankless by CCL
2026